Variant report
Variant | esv3388233 |
---|---|
Chromosome Location | chr6:165286590-165306722 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs9365796 | chr6:165295018-165295019 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs76226593 | chr6:165295055-165295056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527926809 | chr6:165295066-165295067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368232476 | chr6:165295069-165295070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs547965127 | chr6:165295071-165295072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs570906997 | chr6:165295090-165295091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs150121191 | chr6:165295120-165295121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556348020 | chr6:165295155-165295156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569736192 | chr6:165295157-165295158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs535433579 | chr6:165295159-165295160 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs386708295 | chr6:165295169-165295170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9347936 | chr6:165295170-165295171 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs9365797 | chr6:165295179-165295180 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs73019640 | chr6:165295186-165295187 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs138518693 | chr6:165295193-165295194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372786425 | chr6:165295237-165295238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9347937 | chr6:165295240-165295241 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs35270648 | chr6:165295257-165295258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs573709371 | chr6:165295281-165295282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs547728128 | chr6:165295291-165295292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs373871713 | chr6:165295302-165295303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562412788 | chr6:165295405-165295406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527987667 | chr6:165295409-165295410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs188598479 | chr6:165295440-165295441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202086091 | chr6:165295478-165295479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34755537 | chr6:165295496-165295497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs60339779 | chr6:165295498-165295499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192836238 | chr6:165295513-165295514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs564717011 | chr6:165295521-165295522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533336576 | chr6:165295554-165295555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185374301 | chr6:165295561-165295562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569797849 | chr6:165295590-165295591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535498280 | chr6:165295591-165295592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs55941391 | chr6:165295649-165295650 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs548237382 | chr6:165295723-165295724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs565690696 | chr6:165295735-165295736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs116406786 | chr6:165295751-165295752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs370740969 | chr6:165295756-165295757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548716876 | chr6:165295768-165295769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs9347938 | chr6:165295828-165295829 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs141571162 | chr6:165295848-165295849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186996105 | chr6:165295850-165295851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527629265 | chr6:165295862-165295863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536824597 | chr6:165295925-165295926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs557130281 | chr6:165295937-165295938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145892752 | chr6:165295955-165295956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs9365798 | chr6:165295961-165295962 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs559397393 | chr6:165296002-165296003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572716277 | chr6:165296004-165296005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1022147 | chr6:165296018-165296019 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
Chordoma | 18071362 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian cancer | 22355333 | CNVD |
abnormal development | 18461090 | CNVD |
Epilepsy | 22083797 | CNVD |
Myelofibrosis | 22110671 | CNVD |
chordoma | 19801981 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Autism | 17483303 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:165295000-165296200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr6:165295000-165296600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr6:165295400-165296400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr6:165295600-165296400 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr6:165295600-165296400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr6:165295800-165296600 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr6:165296400-165298200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr6:165296400-165298200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr6:165298200-165299000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr6:165298200-165299200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr6:165298200-165299400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
12 | chr6:165302800-165303000 | Enhancers | Right Ventricle | heart |
13 | chr6:165303600-165303800 | Flanking Bivalent TSS/Enh | Aorta | Aorta |
14 | chr6:165303600-165303800 | Enhancers | Right Ventricle | heart |
15 | chr6:165303600-165304200 | Enhancers | Fetal Heart | heart |